Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

NCT06534502 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Seizures
Seizures, Focal
Seizure, Partial Onset
Seizure Disorder, Partial
Seizure, Partial
Epilepsies, Partial
Epilepsy

Interventions

DRUG: Zonisamide Oral Product

Sponsor

Azurity Pharmaceuticals